Key result
Female mice completely resist iron-overload cardiomyopathy, an effect reversed by ovariectomy and rescued by 17β-estradiol.
Estrogen provides marked protection against iron-overload cardiomyopathy in preclinical models, highlighting a potential therapeutic target and explaining sex-related differences in susceptibility.
No takes yet. Share an insight, caveat, or question.
Warrants investigation of estrogen in iron-overload cardiomyopathy; hypothesis-generating and should not change practice.
Das et al. (2017) studied Iron-overload cardiomyopathy. Female sex and 17β-estradiol therapy vs. Male sex and ovariectomy was evaluated on Cardiac function, myocardial fibrosis, and oxidative stress. Female mice were completely protected from iron-overload cardiomyopathy compared to males, an effect reversed by ovariectomy and rescued in males by 17β-estradiol therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: